Technical Analysis for CRSP - CRISPR Therapeutics AG
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 56.22 | 0.99% | 0.55 |
CRSP closed up 0.99 percent on Friday, May 17, 2024, on 79 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: May 30
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Support | Bullish | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| BB Squeeze Ended | Range Expansion | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.99% | |
| BB Squeeze + Upper Band Touch | Range Contraction | 0.99% | |
| Upper Bollinger Band Touch | Strength | 0.99% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -1.30% | |
| Bollinger Band Squeeze | Range Contraction | -1.30% | |
| BB Squeeze + Upper Band Touch | Range Contraction | -1.30% | |
| Inside Day | Range Contraction | -1.30% |
| Alert | Time |
|---|---|
| Possible NR7 | 2 days ago |
| 20 DMA Support | 2 days ago |
| 10 DMA Support | 2 days ago |
| Fell Below Previous Day's Low | 2 days ago |
| Down 1% | 2 days ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/30/2024
Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct disease-associated deoxyribonucleic acid (DNA) in a patient’s cell. The location at which the Cas9 molecular scissors cut the DNA to be edited is specified by guide ribonucleic acid (RNA), which is comprised of a crRNA component and a tracrRNA component, either individually or combined together as a single guide RNA. The Company has business operations in London, the United Kingdom, as well as research and development operations in Cambridge, the United States.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Immune System Acid Genetics Enzymes Genetic Engineering Precision Medicine DNA CRISPR Genome Editing Cas9
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Immune System Acid Genetics Enzymes Genetic Engineering Precision Medicine DNA CRISPR Genome Editing Cas9
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 91.1 |
| 52 Week Low | 37.55 |
| Average Volume | 1,365,382 |
| 200-Day Moving Average | 59.32 |
| 50-Day Moving Average | 62.32 |
| 20-Day Moving Average | 54.94 |
| 10-Day Moving Average | 55.08 |
| Average True Range | 2.91 |
| RSI (14) | 47.09 |
| ADX | 19.57 |
| +DI | 19.28 |
| -DI | 21.50 |
| Chandelier Exit (Long, 3 ATRs) | 50.45 |
| Chandelier Exit (Short, 3 ATRs) | 59.75 |
| Upper Bollinger Bands | 57.86 |
| Lower Bollinger Band | 52.01 |
| Percent B (%b) | 0.72 |
| BandWidth | 10.65 |
| MACD Line | -1.69 |
| MACD Signal Line | -2.49 |
| MACD Histogram | 0.7979 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 58.82 | ||||
| Resistance 3 (R3) | 58.58 | 57.47 | 58.38 | ||
| Resistance 2 (R2) | 57.47 | 56.81 | 57.59 | 58.24 | |
| Resistance 1 (R1) | 56.85 | 56.40 | 57.16 | 57.09 | 58.09 |
| Pivot Point | 55.74 | 55.74 | 55.90 | 55.86 | 55.74 |
| Support 1 (S1) | 55.12 | 55.08 | 55.43 | 55.36 | 54.35 |
| Support 2 (S2) | 54.01 | 54.67 | 54.13 | 54.20 | |
| Support 3 (S3) | 53.39 | 54.01 | 54.06 | ||
| Support 4 (S4) | 53.63 |
